Six key steps to successful technical transfers of high potent oral solid dose drugs
Effectively transitioning a drug manufacturing process to a CDMO always depends on strong communication and well-defined processes. But where high potent oral solid dose drugs are concerned, there is an additional level of safety risk to navigate.
